Cogent Biosciences Statistics Share Statistics Cogent Biosciences has 139.7M
shares outstanding. The number of shares has increased by 4.03%
in one year.
Shares Outstanding 139.7M Shares Change (YoY) 4.03% Shares Change (QoQ) 0.01% Owned by Institutions (%) 99.99% Shares Floating 102.75M Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 13.07M, so 9.35% of the outstanding
shares have been sold short.
Short Interest 13.07M Short % of Shares Out 9.35% Short % of Float 10.62% Short Ratio (days to cover) 13.37
Valuation Ratios The PE ratio is -3.17 and the forward
PE ratio is -7.03.
Cogent Biosciences's PEG ratio is
-1.92.
PE Ratio -3.17 Forward PE -7.03 PS Ratio 0 Forward PS 47.2 PB Ratio 3.16 P/FCF Ratio -3.89 PEG Ratio -1.92
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cogent Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.32,
with a Debt / Equity ratio of 0.07.
Current Ratio 5.32 Quick Ratio 5.32 Debt / Equity 0.07 Debt / EBITDA -0.06 Debt / FCF -0.08 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.25M Employee Count 205 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 21.78% in the
last 52 weeks. The beta is 0.35, so Cogent Biosciences's
price volatility has been higher than the market average.
Beta 0.35 52-Week Price Change 21.78% 50-Day Moving Average 12.12 200-Day Moving Average 8.33 Relative Strength Index (RSI) 61.32 Average Volume (20 Days) 2,732,385
Income Statement
Revenue n/a Gross Profit -4.4M Operating Income -275.94M Net Income -255.86M EBITDA -275.94M EBIT -275.94M Earnings Per Share (EPS) -2.46
Full Income Statement Balance Sheet The company has 98.17M in cash and 17.47M in
debt, giving a net cash position of 80.7M.
Cash & Cash Equivalents 98.17M Total Debt 17.47M Net Cash 80.7M Retained Earnings -859.48M Total Assets 274.82M Working Capital 186.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -207.79M
and capital expenditures -573K, giving a free cash flow of -208.36M.
Operating Cash Flow -207.79M Capital Expenditures -573K Free Cash Flow -208.36M FCF Per Share -2.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields COGT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for COGT is $21,
which is 58.5% higher than the current price. The consensus rating is "Buy".
Price Target $21 Price Target Difference 58.5% Analyst Consensus Buy Analyst Count 10
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 9, 2020. It was a
backward
split with a ratio of 1:4.
Last Split Date Nov 9, 2020 Split Type backward Split Ratio 1:4
Scores Altman Z-Score 1.17 Piotroski F-Score 1
